March 8, 2012 – ST. LOUIS, MO & CLEVELAND, OH – RiverVest Venture Partners today announced that RiverVest V.P. Karen Spilizewski will speak at BioMEMS 2012’s Venture Capital session on March 22.
The conference will focus on MEMS technologies for biomedical applications, or BioMEMS, whose market size is estimated at $1.7 billion. BioMEMS, or the biological and biomedical applications of micro- and nanotechnology, is finding widespread applicability and uses in areas such as diagnostics, therapeutics and tissue engineering.
In addition to her role at RiverVest, Spilizewski is a leader of the medical device team at Cleveland-based BioEnterprise, an initiative to accelerate the growth of healthcare companies and the commercialization of bioscience technologies.
Over the past 20 years, Spilizewski has developed and commercialized products for medical devices and applications including wound care, diagnostics, surgical and electromedical applications. Spilizewski received her MBA, M.S. in Macromolecular Science and a B.S. degree in Biomedical Engineering from Case Western Reserve.
About RiverVest Venture Partners®
RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.
Since its inception in September 2000, RiverVest has raised two investment funds, with total committed capital of $164 million, and supported more than 25 innovative life science companies. For more information, please visit https://www.rivervest.com or follow @RiverVest on Twitter.
BioEnterprise is a business formation, recruitment, and acceleration initiative designed to grow health care companies and commercialize bioscience technologies. Based in Cleveland, BioEnterprise’s founders and partners are Cleveland Clinic, University Hospitals, Case Western Reserve University, Summa Health System and BioInnovation Institute in Akron. For more information, please visit http://www.bioenterprise.com .